Thank you for reading!
Please log in, or sign up for a new account and purchase a subscription to continue reading.
We have used your information to see if you have a subscription with us, but did not find one. Please use the button below to verify an existing account or to purchase a new subscription.
Your current subscription does not provide access to this content. Please use the button below to manage your account.
Joe Raedle/Getty Images
Stacey Abrams has been an outspoken advocate against Georgia s recent restrictive voting laws.
Abrams has helped register thousands of voters in the state over the past decade.
A leadership consultant who s worked with Abrams spoke about what makes her leadership style unique.
Aiko Bethea has had many bosses.
After earning her Juris Doctor from the University of North Carolina at Chapel Hill in 2002, the executive coach and consultant worked as an internal auditor at Bank of America and then as a lawyer at the prestigious international law firm Kilpatrick Townsend & Stockton. She s been the head of diversity and inclusion at the Fred Hutch Research Center and deputy director at the Bill and Melinda Gates Foundation.
Over the past few months, Northwest Advanced Bio-Fuels has been introducing critical Team Members and Partners and discussing the roles they play in our Project
Amgen v. Sanofi affirmed the district court’s judgment as a matter of law invalidating genus claims in U.S. Patent Nos. 8,829,165 and 8,859,741 that recite functional limitations covering Amgen’s cholesterol medication Repatha® by focusing on full scope enablement. Now, Amgen has filed a petition for
en banc rehearing arguing that the panel improperly created a new and heightened test for enablement of genus claims with functional limitations.
1 In the petition, Amgen poses the following questions:
[Question 1:] Whether the panel’s new enablement test for genus claims with functional limitations . . . conflicts with Supreme Court decisions . . . .
[Question 2:] Whether enablement is a question of fact, as the Supreme Court has held, or a question of law, as [the Federal Circuit] holds . . . .
To embed, copy and paste the code into your website or blog:
The Toxic Substances Control Act (TSCA), enacted in 1976, authorizes the United States Environmental Protection Agency (EPA) to regulate the manufacture or importation of new and existing chemicals. TSCA’s regulations include reporting, record-keeping, and testing requirements. TSCA’s scope is very broad – reaching any “person” who manufactures, imports, processes, distributes in commerce, uses or disposes of a chemical substance, regardless of the industry sector. In June 2016, Congress enacted the Lautenberg Act, which sharpened TSCA’s tools for assessment and regulation of both existing and new chemical substances in the marketplace. Consequently, the Trump Administration was the first administration with the opportunity to most fully implement the 2016 Amendments. In the view of its critics, Trump’s EPA exercised its discretion often to the benefit of chemical companies, including a narrower scope for